AI in pharma

Digital

When you attend events hosted by industry leaders like Google, you expect to be impressed by how technology continues to evolve.

Digital

When it comes to GenAI, industry must demand evidence-grounded systems that prioritise verifiable clinical data and rigorous human oversight.

Digital

In 2026, biopharma will move from proving AI works to proving it can be trusted at scale.

Sales & Marketing

As the healthcare landscape continues to evolve rapidly, the tools used to understand it must keep pace.

Digital

The importance of AI in pharma and life sciences cannot be overstated.

R&D

Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.